Kura Oncology Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Thanks so much. Good afternoon, everybody. Welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the Biotech Equity Research Analysts at Barclays. And thank you, everyone, for taking time out of their day, of course. And if you have questions, you can always ping me, institutional investors can e-mail me at [email protected] or ping me on Bloomberg. Because we got great pleasure to introduce the management team from Kura, or at least the CEO, Troy Wilson. Thank you so much for spending time with us this afternoon.
Questions & Answers
And just as an opening question, I just ask all my companies this -- about your -- the core competency of the company and the kind of -- I guess, the differentiation at the core of Kura.
Sure, Peter. So first of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |